2-OADCs |
2-oxo dehydrogenase complex |
AE2 |
anion exchanger 2 |
AMAs |
antimitochondrial antibodies |
ATRA |
all-trans retinoic acid |
Bas |
bile acids |
BDL |
bile duct ligation |
BECs |
biliary epithelial cells |
CCA |
Cholangiocarcinoma |
CCl4
|
C-C Motif Chemokine Ligand 4 |
dnTGFβRII |
dominant-negative form of TGF-β receptor type II |
ECM |
secrete extracellular matrix |
EMT |
epithelial-to-mesenchymal transition |
FUT2 |
glycocalyx stabilising enzyme fucosyltransferase 2 |
UDCA |
ursodeoxycholic acid |
FZD1 |
Frizzled 1 |
GWAS |
genome-wide association study |
HCC |
hepatocellular carcinoma |
Hes1 |
hairy and enhancer of split-1 |
Hh |
Hedgehog |
HLA |
human leukocyte antigen
|
HNFs |
hepatocyte nuclear factors |
HSCs |
hepatic stellate cells |
IBD |
inflammatory bowel disease |
IFNg |
interferon gamma
|
IL-12 |
interleukin 12 |
IL-6 |
interleukin 6 |
JAG2 |
jagged canonical notch ligand 2 |
JNKs |
c-Jun N-terminal kinases |
LRP5/6 |
low-density lipoprotein receptor-related protein5/6 |
MAIT |
mucosal-associated invariant T cells |
MRC |
magnetic resonance cholangiography |
NF-κB |
nuclear factor kappa-light-chain-enhancer of activated B cells |
NTPD2 |
ecto-ATPase nucleoside triphosphate diphosphohydrolase-2 |
OCA |
obeticholic acid |
PBC |
primary biliary cholangitis |
PC |
primary cilium |
PDC-E2 |
pyruvate dehydrogenase complex |
PFs |
portal fibroblasts |
PLD |
polycystic liver disease |
PSC |
primary sclerosing cholangitis |
p75NTR |
p75 neurotrophin receptor |
SOX4 |
SRY-box transcription factor 4 |
SOX9 |
SRY-box transcription factor 9 |
TGF-β |
transforming growth factor beta |
TGR5 |
Takeda G protein-coupled receptor 5 |
TNF-α |
tumour necrosis factor-α |
UDCA |
ursodeoxycholic acid |
YAP1 |
Yes-associated protein 1 |
αSMA |
α-smooth muscle actin |